AGENDA | JUNE 10 | 12:00 PM EDT
12:00 - 12:10 PM
Welcome & Opening Remarks
12:10 12:50 PM
Collaborative Case Studies
12:50 - 2:15 PM
2:15 - 3:05 PM
Industry Insights on Partnering and Collaboration
3:05 - 3:10 PM
3:10 - 4:00 PM
PROUDLY SPONSORED BY:
Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies, is one of the world's best-known and most respected health care brands, solely focused on protecting, enhancing and restoring people's eyesight.
Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. Through Surgical, Pharmaceutical and Vision Care, Alcon offers the world’s widest spectrum of ophthalmic products, helping millions of patients see the world better with clarity, color and beauty.
Promedica International is a privately held, full-service, ISO-certified CRO providing clinical trial services for the medical device, biotechnology and pharmaceutical industries. Founded in 1985, Promedica International, a woman-owned corporation, is headquartered in Orange County, California. We have successfully been providing exceptional value to our clients for over 30 years in clinical trial project management, site recruitment and management, clinical study monitoring, data management, biostatistics, medical writing and GCP auditing.
Biolight Life Sciences
Biolight Life Sciences Ltd. is a leading company that invests in companies and manages projects in the field of diseases and eye treatments. Biolight's portfolio companies are engaged in advanced medical equipment, drugs, diagnostics and digital medicine and all illustrate the enormous potential of Israeli innovation in these fields.
Orasis Pharmaceuticals is an emerging ophthalmic pharmaceutical company focused on developing an innovative eye drop for the treatment of presbyopia symptoms. Promising results from a well powered Phase 2b study have paved an informed path for Orasis to advance their product candidate through successful initiation of Phase 3 studies, NEAR-1 and NEAR-2. Orasis’ differentiated formulation with an optimal balance between efficacy, safety and comfort, along with a proven commercialization strategy in place, positions the company as an emerging leader in the presbyopia space. Follow us on LinkedIn to learn more.